Cyclodextrin News

Chloroquine against Covid-19?

The antimalarial drug, chloroquine has been claimed effective in the treatment of patients infected by the novel emerged coronavirus, Covid-19

Due to the reported high ability of virulence of COVID_19 in recent months, several studies have been conducted to discover

ICND 2020 is going to be held during April 15-17, 2020 in Radisson Narita, Tokyo, Japa in collaboration with European

The Novel Coronavirus (COVID-19) has infected more than 60,000 people in over two dozen countries. Considering its global influence, travel

Due to the spreading of the corona-virus the 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (which was initially

Prof. Kaneto Uekama (Professor Emeritus of Kumamoto Uuniversity, Advisor of the Society of Cyclodextrins, Japan) was awarded the Order of

Cyclodextrins have not been popular excipients for nasal or pulmonary drug delivery so far. This can change soon, with the

Following our successful 3rd World Congress and Expo on Nanotechnology and Materials Science in Dubai, UAE on 25-27 June 2018,

Oculis reported positive results from Phase 2 clinical studies of OCS-01 for treating DME

Gilead Sciences’ SBECD-enabled remdesivir (GS-5734) was highlighted in the New England Journal of Medicine last week for treating the first